JPRN-UMIN000014894CompletedPhase 2
Randomized phase II trial of chemoradiotherapy with S-1 versus gemcitabine and S-1 combination therapy as neoadjuvant treatment in patients with resecatble pancreatic cancer - Randomized phase II trial of chemoradiotherapy with S-1 versus gemcitabine and S-1 combination therapy as neoadjuvant treatment in patients with resecatble pancreatic cancer (JASPAC 04)
Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC)0 sites103 target enrollmentStarted: August 19, 2014Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 103
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 79years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1 Treatment history with gemcitabine or fuluoruracil, 2 Use of flucytosine, phenytoin, and warfarin potassium, 3 Fibroid lung or interstitial pneumonia, 4 Pleural lung or ascites 5 Watery diarrhea, etc
Investigators
Similar Trials
Completed
Phase 2
A Randomized phaseII trial of chemoradiotherapy with UFT versus S-1 for low rectal cancerrectal cancer,lower tumor margin is below the peritoneal reflectionJPRN-UMIN000001704Tokushima university60
Active, not recruiting
Not Applicable
A Phase 2, Randomized Trial of Chemoradiation with or withoutPanitumumab in Subjects with Unresected, Locally Advanced Squamous CellCarcinoma of the Head and NeckEUCTR2007-001439-74-FIAmgen Inc150
Active, not recruiting
Not Applicable
A Phase 2, Randomized Trial of Chemoradiation with or withoutPanitumumab in Subjects with Unresected, Locally Advanced Squamous CellCarcinoma of the Head and NeckEUCTR2007-001439-74-HUAmgen Inc246
Active, not recruiting
Phase 1
A Phase 2, Randomized Trial of Chemoradiation with or without Panitumumab in Subjects with Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and NeckAdvance Squamous Cell Carcinoma of the Head and NeckMedDRA version: 9.1 Level: LLT Classification code 10060121 Term: Squamous cell carcinoma of head and neckEUCTR2007-001439-74-GBAmgen Inc246
Active, not recruiting
Not Applicable
A Phase 2, Randomized Trial of Chemoradiation with or withoutPanitumumab in Subjects with Unresected, Locally Advanced Squamous CellCarcinoma of the Head and NeckAdvance Squamous Cell Carcinoma of the Head and NeckMedDRA version: 9.1Level: LLTClassification code 10060121Term: Squamous cell carcinoma of head and neckEUCTR2007-001439-74-DEAmgen Inc246